Welcome to Who Wants to be an APNA Millionaire!
|
|
|
- Hubert Campbell
- 9 years ago
- Views:
Transcription
1 Welcome to Who Wants to be an APNA Millionaire! Drug-Drinks Interactions Drug-Drug Interactions Mary Gutierrez, PharmD, BCPP Clinical Professor of Pharmacy Practice (Psychiatry) Chapman University, School of Pharmacy Your patient drinks 2-3 cups of coffee a day. He was started on a SSRI a week ago. He now complains that he is very jittery and his blood pressure is high. Which of the following SSRIs can increase the concentration of caffeine by 4-5 fold? Citalopram Fluvoxamine Paroxetine Fluoxetine Fluvoxamine strong binding affinity significant 1A2 inhibition decrease metabolism by 80% (increase 4-5 fold) and increase half-life by 500% (from 5.7 hrs to 28.5 hours!) Ki (binding affinity) is 0.2 vs for fluoxetine, norfluoxetine, paroxetine, sertaline and desmethylsertraline. The smaller the Ki number, the stronger the affinity. Excessive caffeine!! hypnotics for insomnia, antihypertensives for high blood pressure, beta-blockers for tachycardia?! Mary Gutierrez, PharmD, BCPP 1
2 Which of the following drinks has the highest concentrations of caffeine? One drink can have the same conc of 10 cups of coffee when taking together with fluvoxamine or other CYP1A2 inhibitors (e.g., ciprofloxacin)? A: 5 Hour Energy B: Monster Energy C: Starbucks Doubleshot D: Red Bull Which of the following antipsychotic agents can have increased concentrations and effects with consumption of excessive caffeine intake (>750 mg/day)? A: Clozapine B: Risperdal C: Quetiapine D: Lurasidone Mary Gutierrez, PharmD, BCPP 2
3 22% psychiatric inpatients vs. 9% of the general population consume > 750 mg caffeine a day. A 19-year-old woman on long-term clozapine therapy developed unexpected clozapine toxicosis. She had been drinking 6 caffeinated cola drinks per day. Stopping the cola intake was followed by a substantial reduction in clozapine concentrations. In a study of 7 patients on clozapine who drank caffeinated beverages, stopping caffeine for 5 days resulted in a 47% reduction in clozapine plasma concentrations. After resuming the caffeine intake, their clozapine concentrations return to the original levels. Patients on clozapine should avoid wide fluctuations in their caffeine intake. Clinicians should consider changes in caffeine intake in patients on clozapine who develop unexpected clozapine toxicosis or lack of clozapine response. (JR Horn and PD Hansten. Caffeine and Clozapine. ww.pharmacytimes.com/publications/issue/2013/july2013/caffeineand-clozapine) Your patient drinks 7-8 cups of coffee a day. He was advised to switched to decaf coffee because of his HTN. Which of the following mood stabilizers can have increased concentrations when your patient stopped drinking caffeinated beverages? A: Lithium B: Carbamazepine C: Valproic acid D: Lamotrigine Elimination of caffeine from the diet of lithiumtreated patients should be done cautiously, especially in patients with high baseline lithium blood levels Less caffeine would allow the use of lower doses of lithium to achieve the same blood since lithium is 100% renal eliminated, and affected by increased or decreased renal clearance Mester R at al. Caffeine Withdrawal Increases Lithium Blood Levels. Bio Psychiatry 1995;37: Jefferson JW. Lithium tremor and caffeine intake: two cases of drinking less and shaking more. J Clin Psychiatry 1988; 49:72 3. Mary Gutierrez, PharmD, BCPP 3
4 Which of the following antidepressants can have a pharmacodynamic interaction (additive effects on blood pressure and heart rate ) with caffeinated drinks or products? A: Citalopram B: Levomilnacipran C: Vortioxetine D: Escitalopram Levomilnacipran is a serotonin and norepinephrine reuptake inhibitor (SNRI) for the treatment of major depressive disorder. This SNRI differs from previously SNRIs in having twice the potency for NE versus 5-HT reuptake inhibition. Common adverse events occurring twice as often as on placebo include tachycardia and palpitations. Similar to other SNRIs, it warrants monitoring of blood pressure and should be used with caution in individuals with pre-existing hypertension. Mago R et al. Levomilnacipran: a newly approved drug for treatment of major depressive disorder. Expert Rev Clin Pharmacol 2014; 7: Levomilnacipran (Fetzima ) National Drug Monograph VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist Executives. CONGRATULATIONS! You ve Reached the $1,000 Milestone! Mary Gutierrez, PharmD, BCPP 4
5 Grapefruit juice can increase the concentrations and toxicity risks for which of the following mood stabilizers? A: Lithium B: Carbamazepine C: Valproic acid D: Lamotrigine Lithium 100% renally eliminated, no hepatic metabolism Carbamazepine (Tegretol) metabolized by CYP3A4 Lamotrigine (Lamictal) metabolized by glucuronic acid conjugation, no CYP450 enzyme metabolism Valproic acid (Depakote) metabolized by non CYP3A4 oxidative pathways (mitochondrial beta-oxidation) and glucuronidation. Which of the following neuropsychiatric agents can be increased with concurrent use of valproic acid (Depakote)? A: Diazepam B: Lamotrigine C: Phenytoin D: All of the above Mary Gutierrez, PharmD, BCPP 5
6 Valproic acid (Depakote) Can increase the concentrations of diazepam, lamotrigine, phenytoin, phenobarbital, warfarin MOA: valproic acid may cause enzyme inhibition of CYP2C9, glucuronidation, and protein binding displacement (increase the unbound drug of concurrently used drug increased pharmacologic actions and side effects) Caution with concurrent use of valproic acid and lamotrigine. Can increase lamotrigine concentrations by 2-fold. NMT mg/day with lower initial dose and increments. Your patient is on atorvastatin (Lipitor) and quetiapine (Seroquel). He asked you if he can drink his grapefruit juice in the morning and medications at night to avoid the drug interaction? Your answer is A: Yes B: No C: Maybe D: I don t know Half-life of grapefruit juice is about 12 hours. Wash out period may take 3 days Mary Gutierrez, PharmD, BCPP 6
7 Which of the following anxiolytic and hypnotic agents have the most significant interactions (increase concentrations by > 9-fold) with grapefruit juice? A: Alprazolam B: Buspirone C: Zolpidem D: Survorexant All are metabolized by CYP3A4 enzymes, but some have more intestinal 3A4 metabolism than others 99% of buspirone (Buspar) metabolism is via intestinal 3A4 metabolism plasma concentrations can be increased by 9.2 fold! Alprazolam (Xanax) has hepatic CYP3A4 metabolism, with significantly less intestinal 3A4 metabolism increase is not significant with GFJ Zolpidem (Ambien) use lower dose or avoid GFJ Suvorexant (Belsomra) dose is recommended at 5 mg, NMT 10 mg is needed. Usual dose is mg/night Which of the following antipsychotic agents is metabolized by CYP3A4 and can have interactions with grapefruit juice? A: Risperidone B: Lurasidone C: Asenapine D: Olanzapine Mary Gutierrez, PharmD, BCPP 7
8 Second generation antipsychotic agents metabolism: Clozapine (Clozaril) 1A2 Olanzapine (Zyprexa) 1A2 Asenapine (Saphris) 1A2 Risperidone (Risperdal) 2D6 Paliperidone (Invega) 2D6 Aripripazole (Abilify) 2D6 and 3A4 Iloperidone (Fanapt) 2D6 and 3A4 Quetiapine (Seroquel) 3A4 Ziprasidone (Geodon) 1/3 via 3A4 Lurasidone (Latuda) 3A4 CONGRATULATIONS! You ve Reached the $32,000 Milestone! Which of the following antipsychotic agents is metabolized by CYP1A2, but has CYP2D6 inhibitory property which can increase paroxetine by 2-fold? A: Clozapine B: Olanzapine C: Asenapine D: All of the above Mary Gutierrez, PharmD, BCPP 8
9 Clozapine (Clozaril) 1A2 Olanzapine (Zyprexa) 1A2 Asenapine (Saphris) SL 1A2, 2D6 inhibitor -> increase conc of paroxetine and other 2D6 drugs Which of the following drinks can decrease the concentrations of psychostimulants? A: Emergen C B: Red Bull C: Grapefruit juice D: Coffee Most drugs are either weak acids or weak bases. Psychostimulants (e.g., Ritalin, Adderall) are chemically weak bases. Acidifying the urine with vitamin C (ascorbic acid) > 2 gm can increase excretion of the weak bases -> decrease concentrations of the psychostimulants Mary Gutierrez, PharmD, BCPP 9
10 Which of the following OTC drinks can increase the concentrations of psychostimulants? A: Emergen C B: Nyquil C: Alka Seltzer D:None of the above Alka Seltzer has Sodium Bicarbonate (1916 mg) Psychostimulants (e.g., Ritalin, Adderall) are chemically weak bases. Increased ph of the urine with sodium bicarbonate can decrease the excretion of the weak bases -> increase concentrations of the psychostimulants Alka Seltzer has a formulation with aspirin. Which of the following mood stabilizer is highly protein bound, and aspirin can cause more free unbound concentrations? A: Tegretol B: Depakote C: Trileptal D: Lithium Mary Gutierrez, PharmD, BCPP 10
11 Aspirin is known to displace a number of drugs from protein binding sites including warfarin (99%) and valproic acid (95% BP) Aspirin itself is not highly protein bound, but it changes the structure of the serum albumin > less binding protein > more unbound drug > increased effects Patients with chronic alcohol use -> CYP450 2E1 enzyme induction -> Increased production of hepatotoxic metabolite NAPQI from acetaminophen. Patients should be advised to use NMT mg/day of acetaminophen.?would this apply to patients on CBZ? A: 1,000 B: 2,000 C: 3,000 D: 4,000 YOU HAVE WON $1 MILLION DOLLARS IN DRUG INTERACTIONS IQ! Mary Gutierrez, PharmD, BCPP 11
PSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS. Juanaelena Garcia, MD Psychiatry Director Institute for Family Health
PSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS Juanaelena Garcia, MD Psychiatry Director Institute for Family Health Learning Objectives Learn basics about the various types of medications that
Medication Side Effects:
Medication Side Effects: Staying Healthy While on Psychotropic Medications Megan Maroney PharmD, BCPP Clinical Assistant Professor Ernest Mario School of Pharmacy Rutgers the State University of New Jersey
ATYPICALS ANTIPSYCHOTIC MEDICATIONS
The atypical antipsychotics are a class of drugs that are used to treat a number of behavioral health disorders, including schizophrenia, other psychotic disorders, mood disorders, and behavioral agitation
New Treatments. For Bipolar Disorder. Po W. Wang, MD Clinical Associate Professor Bipolar Disorders Clinic Stanford University School of Medicine
New Treatments For Bipolar Disorder Po W. Wang, MD Clinical Associate Professor Bipolar Disorders Clinic Stanford University School of Medicine Abbott Laboratories AstraZeneca Bristol-Myers Squibb Corcept
PSYCHOSOMATIC INSTITUTE OF SAN ANTONIO New Patient Information
PSYCHOSOMATIC INSTITUTE OF SAN ANTONIO New Patient Information Name: Last: First: MI: Birth Date: Sex: M F Marital Status: Single Married Divorced Separated Widowed Partnered Other Preferred name: Emergency
Psychiatric Medications: Pearls and Pitfalls. The majority of medications used in patients with psychiatric diagnoses have more than one use.
Psychiatric Medications: Pearls and Pitfalls Rule #1 The majority of medications used in patients with psychiatric diagnoses have more than one use. Without access to the patient s medical record, to review
Pharmacokinetics: Do we know what we are doing? Prof Dana Niehaus Department of Psychiatry University of Stellenbosch
Pharmacokinetics: Do we know what we are doing? Prof Dana Niehaus Department of Psychiatry University of Stellenbosch Content Pharmacokinetics (What the body does to the drug) Absorption Distribution Metabolism
Bipolar Disorder. Mania is the word that describes the activated phase of bipolar disorder. The symptoms of mania may include:
Bipolar Disorder What is bipolar disorder? Bipolar disorder, or manic depression, is a medical illness that causes extreme shifts in mood, energy, and functioning. These changes may be subtle or dramatic
PSYCHIATRY. Patient Name: Date: / / Date of Birth: / / Age: Pharmacy Name: Pharmacy Phone #:
Patient Name: Date: / / Date of Birth: / / Age: Pharmacy Name: Pharmacy Phone #: Primary Care Physician: Current Therapist/Counselor: How did you hear about us? Internet Insurance Other Providers (specialty):
Lamictal, lamotrigine Lithium, lithobid, eskalith Depakote, valproate Trileptal, oxcarbazepine Tegretol, equetro, carbamazepine Atypicals (aripiprazole, abilify, olanzapine, zyprexa, invega, risperdal,
Overview of Mental Health Medication Trends
America s State of Mind Report is a Medco Health Solutions, Inc. analysis examining trends in the utilization of mental health related medications among the insured population. The research reviewed prescription
Direct antiviral therapy of hcv and relevant drug drug interactions for ivdu
Direct antiviral therapy of hcv and relevant interactions for ivdu Stefan Mauss Center for HIV and Hepatogastroenterology Duesseldorf, Germany Disclosures Advisory board: Abbvie, BMS, Boehringer Ingelheim,
Antipsychotics and the Nursing Home
Antipsychotics and the Nursing Home Lisa M. O Hara, PharmD, CGP Corporate Director of Clinical Services The State Operations Manual Part 1: F329 Unnecessary Drugs Medication Management Defined Helps promote
Medications for bipolar disorder
Medications for bipolar disorder Findings from Australian National Survey of Mental Health and Wellbeing (Mitchell et al, 2004) In 12 months, only one-third saw a mental health professional 40% received
Comorbid Conditions in Autism Spectrum Illness. David Ermer MD June 13, 2014
Comorbid Conditions in Autism Spectrum Illness David Ermer MD June 13, 2014 Overview Diagnosing comorbidities in autism spectrum illnesses Treatment issues specific to autism spectrum illnesses Treatment
Objectives. Depression and Anxiety: Latest in treatment recommendations. At the conclusion of this presentation the attendee will be able to:
Depression and Anxiety: Latest in treatment recommendations Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC President, Fitzgerald Health Education Associates, Inc., North Andover, MA Family
Excerpt from Food-Medication Interactions 13th edition by Zaneta M. Pronsky, MS, RD, LDN, FADA INTRODUCTION
Excerpt from Food-Medication Interactions 13th edition by Zaneta M. Pronsky, MS, RD, LDN, FADA INTRODUCTION The study of the absorption, distribution, metabolism and excretion of drugs is referred to as
Medications for Huntington s Disease Vicki Wheelock, M.D.
Medications for Huntington s Disease Vicki Wheelock, M.D. Director, HDSA Center of Excellence at UC Davis June 4, 2013 Outline Introduction and disclaimers Medications for cognitive symptoms Medications
State of Louisiana. Department of Health and Hospitals Bureau of Health Services Financing
Bobby Jindal GOVERNOR State of Louisiana Department of Health and Hospitals Bureau of Health Services Financing Kathy H. Kliebert SECRETARY The purpose of this memo is to advise you that effective September
Lithium. Generic name = lithium carbonate (tablets and capsules), or lithium citrate (liquid)
Lithium Brand and Generic Names Eskalith - Capsules: 300 mg Eskalith CR slow release - Tablets: 450 mg Lithobid slow release - Tablets: 300 mg Generic name = lithium carbonate (tablets and capsules), or
Alcohol Withdrawal. Introduction. Blood Alcohol Concentration. DSM-IV Criteria/Alcohol Abuse. Pharmacologic Effects of Alcohol
Pharmacologic Effects of Alcohol Alcohol Withdrawal Kristi Theobald, Pharm.D., BCPS Therapeutics III Fall 2003 Inhibits glutamate receptor function (NMDA receptor) Inhibits excitatory neurotransmission
BIPOLAR DISORDER A GUIDE FOR INDIVIDUALS AND FAMILIES FOR THE TREATMENT OF BIPOLAR DISORDER IN ADULTS
BIPOLAR DISORDER A GUIDE FOR INDIVIDUALS AND FAMILIES FOR THE TREATMENT OF BIPOLAR DISORDER IN ADULTS A publication of the Massachusetts Department of Mental Health and the Massachusetts Division of Medical
Medications Used in the Management of Disruptive Behavior Disorders
The following medication chart is provided as a brief guide to some of the medications used in the management of various behavior disorders, along with their potential benefits and possible side effects.
Handy charts to help people compare the medications for mental health conditions
Handy charts Handy charts to help people compare the medications for mental health conditions Contents: 1. Acute Psychiatric Emergency 2. ADHD (Attention Deficit Hyperactivity Disorder) 3. Alcohol Dependence
Handout 2 List of medications used to treat mental illness
Navigating Boundaries: Setting Sail With A Mentally Ill Client Handout 2 List of medications used to treat mental illness Information synthesized from www.drugs.com. Additional Information: CR following
Psychotropic Medication Reference Chart
Psychotropic Medication Reference Chart Appendix 4.14 This chart is not an all-inclusive list of medications. If you have a question regarding the classification of a medication you may consult websites
1/23/2014 TOPICS PHARMACOLOGY: UPDATES AND REVIEW. Elizabeth Reeve MD HealthPartners Medical Group Gillette Children s Specialty Heath Care
PHARMACOLOGY: UPDATES AND REVIEW Elizabeth Reeve MD HealthPartners Medical Group Gillette Children s Specialty Heath Care TOPICS General pharmacology concepts when prescribing for children and adults When
Bipolar Disorder: What s the Difference & What s New?
Bipolar Disorder: What s the Difference & What s New? Rex S. Lott, Pharm.D., BCPP Professor, Idaho State University College of Pharmacy Mental Health Clinical Pharmacist, Boise VA Medical Center Clinical
Early Morning Waking Excessively Orderly or Perfectionistic
COLLEGE OF MEDICINE Jacksonville 580 W 8 th St T-2 6 th Fl Ste 6005 6266 Dupont Station Ct Department of Psychiatry Jacksonville, FL 32209 Jacksonville, Fl 32217 Division of Adult Psychiatry Phone 904-383-1038
Analysis of New Brand Name Drugs for MDD and Bipolar I Depression/Schizophrenia. By Minh Vo, DO
Analysis of New Brand Name Drugs for MDD and Bipolar I Depression/Schizophrenia By Minh Vo, DO Fetzima Brand: Fetzima Generic: levomilnacipran (generic not available) Commonly Prescribed for: major depressive
Mental Health Medications
Mental Health Medications National Institute of Mental Health U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Contents Mental Health Medications..............................................................1
Medications A detailed booklet that describes mental disorders and the medications for treating them includes a comprehensive list of medications.
A detailed booklet that describes mental disorders and the medications for treating them includes a comprehensive list of medications. 2014 Contents Introduction: Mental Health Medications...1 What are
Benzodiazepines: A Model for Central Nervous System (CNS) Depressants
Benzodiazepines: A Model for Central Nervous System (CNS) Depressants Objectives Summarize the basic mechanism by which benzodiazepines work in the brain. Describe two strategies for reducing and/or eliminating
Workshop: Management of Depression in the Primary Care Setting, Kaiser Permanente of Ohio s Multidisciplinary Model
Workshop: Management of Depression in the Primary Care Setting, Kaiser Permanente of Ohio s Multidisciplinary Model Larissa Elgudin, MD, Chief of Behavioral Health Services Colleen O Malley RN, BSN, Regional
Genome wide association study of extreme obesity defined by electronic medical record phenotyping
1 Genome wide association study of extreme obesity defined by electronic medical record phenotyping The pseudo code and flowchart for Geisinger extreme obesity cohort are below. Questions regarding this
MOOD DISORDERS PART II BIPOLAR AFFECTIVE DISORDER (BAD) Todd Stull, M.D. James Sorrell, M.D.
MOOD DISORDERS PART II BIPOLAR AFFECTIVE DISORDER (BAD) Todd Stull, M.D. James Sorrell, M.D. BIPOLAR AFFECTIVE DISORDER (BAD) General Assessment is challenging Input important Change in level of functioning
SESSION K2. When SSRIs Are Not Enough, What Then?
37th Annual Advanced Practice in Primary and Acute Care Conference: October 9-11, 2014 SESSION K2 3:55 When SSRIs Are Not Enough, What Then? Scott MacHaffie, MN, ARNP S E S S I O N Session Description:
A few general principles regarding medications are important to consider before initiating therapy in individuals diagnosed with a dementia
MEDICATIONS USED FOR THE MANAGEMENT OF DEMENTIA AND RELATED BEHAVIORIAL COMPLICATIONS* R.Ron Finley, B.S Pharm, R.Ph,CGP, Aimee Loucks, Pharm. D., Gil D. Rabinovici, M.D The following is intended to be
Serenity Psychiatry, LLC Mimi Armellino, DO Of Coastal Counseling Associates. Patient History Form
Serenity Psychiatry, LLC Mimi Armellino, DO Of Coastal Counseling Associates Patient History Form Name Date Age DOB SSN Address City State ZIP Patient s Telephone (H) (W) (Cell) Email Job Title or School
Pharmacotherapy of BPSD. Pharmacological interventions. Anti-dementia drugs. Abhilash K. Desai MD Medical Director Alzheimer s Center of Excellence
Pharmacotherapy of BPSD Abhilash K. Desai MD Medical Director Alzheimer s Center of Excellence Pharmacological interventions Reducing medication errors. Reducing potentially inappropriate medication prescription.
Antidepressant treatment in adults
Antidepressant treatment in adults A NICE pathway brings together all NICE guidance, quality standards and materials to support implementation on a specific topic area. The pathways are interactive and
Medication Glossary Drug Classes and Medications
Understanding Lewy Body Dementia Lewy body dementia (LBD) is a brain disorder that impairs thinking, movement, sleep and behavior. It also affects autonomic body functions, such as blood pressure control,
Systematic Review of Treatment for Alcohol Dependence
Systematic Review of Treatment for Alcohol Dependence ALCOHOL ARCUATE NUCLEUS in Hypothalamus, pituitary Beta-endorphin Dynorphin Kappa receptor Nucleus Enkephalins accumbens Delta receptor (+) Mu receptor
Arizona Department of Health Services/ Division of Behavioral Health Services Behavioral Health Drug List Effective 1/1/2014
Arizona Department of Health Services/ Division of Behavioral Health Services Behavioral Health Drug List Effective 1/1/2014 The Arizona Department of Health Services, Division of Behavioral Health Services,
DEMENTIA EDUCATION & TRAINING PROGRAM
The pharmacological management of aggression in the nursing home requires careful assessment and methodical treatment to assure maximum safety for patients, nursing home residents and staff. Aggressive
Measuring Generic Efficiency in Part D
Measuring in Part D Rates among Medicare Part D Generic efficiency rate is a measurement of the total number of prescrip=ons filled as a generic for products with a direct generic subs=tute within a therapeu=c
COMPREHENSIVE MANAGEMENT OF THE ELDERLY PATIENT WITH MANIA
COMPREHENSIVE MANAGEMENT OF THE ELDERLY PATIENT WITH MANIA Manic depressive illness is a biological brain disorder that produces significant alterations of mood and psychosis. Mania in the elderly occurs
Psychopharmacology. Psychopharmacology. Hamish McAllister-Williams Reader in Clinical. Department of Psychiatry, RVI
Regional Affective Disorders Service Psychopharmacology Northumberland, Tyne and Wear NHS Trust Hamish McAllister-Williams Reader in Clinical Psychopharmacology Department of Psychiatry, RVI Intro NOT
Using Antipsychotics to Treat: Depression. Comparing Effectiveness, Safety, and Price
Using Antipsychotics to Treat: Depression Comparing Effectiveness, Safety, and Price Our Recommendations Although antipsychotics were developed to treat schizophrenia, newer ones are sometimes used to
Bipolar Disorder Practice Guidelines for Adults
Bipolar Disorder Practice Guidelines for Adults Introduction PerformCare s condensed guidelines for the treatment of Bipolar Disorder are derived from the American Psychiatric Association (APA) Guidelines
Clozapine: Treat the Patient or Treat the Level?
RCPsych International Conference 2014 Clozapine: Treat the Patient or Treat the Level? Bob Flanagan Toxicology Unit Clinical Biochemistry Bessemer Wing Denmark Hill London SE5 9RS Tel: 020 3299 5824 Fax:
A BRIEF OVERVIEW OF PSYCHOTROPIC MEDICATION USE FOR PERSONS WITH INTELLECTUAL DISABILITIES
INTRODUCTION A BRIEF OVERVIEW OF PSYCHOTROPIC MEDICATION USE FOR PERSONS WITH INTELLECTUAL DISABILITIES Individuals with intellectual disabilities are not uncommonly prescribed psychotropic medications.
Nursing 113. Pharmacology Principles
Nursing 113 Pharmacology Principles 1. The study of how drugs enter the body, reach the site of action, and are removed from the body is called a. pharmacotherapeutics b. pharmacology c. pharmacodynamics
CNS prescription drugs and their ability to impair, y. Antidepressants. Indications for the existence of behavioral toxicity of antidepressants
CNS prescription drugs and their ability to impair, y FACTA 1 JG Ramaekers, Dept Neuropsychology & Psychopharmacology Maastricht University, The Netherlands ([email protected]) TCAs RIMAs
Brand Name: Brintellix. Generic Name: Vortioxetine. Manufacturer 5 : Takeda Pharmaceuticals, Inc. Drug Class 2,5 : Antidepressant, Piperazine
Brand Name: Brintellix Generic Name: Vortioxetine Manufacturer 5 : Takeda Pharmaceuticals, Inc. Drug Class 2,5 : Antidepressant, Piperazine Uses: Labeled Uses 1,2,3,4,5 : Major depressive disorder Unlabeled
Primary Care Guide For Prescription Of Anxiolytic Medications For Persons With Mental Retardation and Developmental Disabilities (MR/DD)
Primary Care Guide For Prescription Of Anxiolytic Medications For Persons With Mental Retardation and Developmental Disabilities (MR/DD) Overview of Prescription The DD/MR patient may develop symptoms
Psychotherapeutic Medications
Psychotherapeutic Medications 2011 What Every Counselor Should Know n Generic and Brand Medication Names n Purpose n Usual Dose and Frequency n Potential Side Effects n Emergency Conditions n Cautions
TREATMENT-RESISTANT DEPRESSION AND ANXIETY
University of Washington 2012 TREATMENT-RESISTANT DEPRESSION AND ANXIETY Catherine Howe, MD, PhD University of Washington School of Medicine Definition of treatment resistance Failure to remit after 2
MEDICATION GUIDE. TRINTELLIX [trin -tel-ix] (vortioxetine) Tablets
MEDICATION GUIDE TRINTELLIX [trin -tel-ix] (vortioxetine) Tablets Read this Medication Guide before you start taking TRINTELLIX and each time you get a refill. There may be new information. This information
Asenapine (Saphris) for bipolar I disorder
Asenapine (Saphris) for bipolar I disorder This Medicine Update is for people with bipolar I disorder who are taking, or thinking about taking, asenapine. Summary Asenapine is an antipsychotic medicine.
Objectives. The use of Psychotropics in Children
Objectives The use of Psychotropics in Children Ashley E. Little, Pharm.D. Psychopharmacology Resident Nova Southeastern University College of Pharmacy Dade County Pharmacy Association To understand current
Paxil/Paxil-CR (paroxetine)
Generic name: Paroxetine Available strengths: 10 mg, 20 mg, 30 mg, 40 mg tablets; 10 mg/5 ml oral suspension; 12.5 mg, 25 mg, 37.5 mg controlled-release tablets (Paxil-CR) Available in generic: Yes, except
Psychotropic Medication
Page 1 T I P S F O R P R A C T I C E Psychotropic Medication Psychotropic medications are symptomatic medications that affect attention, emotions, or behaviors. Communication between the physician, NDHHS
1. Which of the following SSRIs requires up to a 5-week washout period because of the
1 Chapter 38. Major Depressive Disorders, Self-Assessment Questions 1. Which of the following SSRIs requires up to a 5-week washout period because of the long half-life of its potent active metabolite?
Depression. Medicines To Help You
Medicines To Help You Depression Use this guide to help you talk to your doctor, pharmacist, or nurse about your medicines for depression. The guide lists all of the FDA-approved products now available
Clinically Significant Cardiovascular. Drug Interactions. April 30, 2014 Michael A Militello, PharmD, BCPS Cardiovascular Clinical Pharmacist
Clinically Significant Cardiovascular Drug Interactions April 30, 2014 Michael A Militello, PharmD, BCPS Cardiovascular Clinical Pharmacist Introduction Drug interactions represent 3-5% of preventable
The following is a sample of psychotropic drug warnings that drug regulatory agencies
Chronology of International Drug Regulatory Agency Warnings about Psychotropic Drugs The following is a sample of psychotropic drug warnings that drug regulatory agencies around the world have issued.
Summary of the risk management plan (RMP) for Cerdelga (eliglustat)
EMA/743948/2014 Summary of the risk management plan (RMP) for Cerdelga (eliglustat) This is a summary of the risk management plan (RMP) for Cerdelga, which details the measures to be taken in order to
Clinical Recommendations for Treatment of Bipolar Disorder for Hong Kong 2013
Clinical Recommendations for Treatment of Bipolar Disorder for Hong Kong 2013 Version: March 2013 Objectives of Treatment Rapid control of symptoms especially agitation, impulsivity, aggression, suicidality
Psychotic Disorder. Psychosis. Psychoses may be caused by: Examples of Hallucinations and Delusions 12/12/2012
Psychosis Psychotic Disorder Dr Lim Boon Leng Psychiatrist and Medical Director Dr BL Lim Centre For Psychological Wellness Tel: 64796456 Email: [email protected] Web: www.psywellness.com.sg A condition
Depression is a common biological brain disorder and occurs in 7-12% of all individuals over
Depression is a common biological brain disorder and occurs in 7-12% of all individuals over the age of 65. Specific groups have a much higher rate of depression including the seriously medically ill (20-40%),
Clinical Summary of Pediatric Metabolic AERS Reports. Judith Cope, MD, MPH Office of Pediatric Therapeutics/FDA
Clinical Summary of Pediatric Metabolic AERS Reports Judith Cope, MD, MPH Office of Pediatric Therapeutics/FDA 1 Clinical Summary of Pediatric Metabolic AERS Reports: Atypical Antipsychotics n=100 reports;
The Road to Rehabilitation
The Road to Rehabilitation Part 6 Mapping the Way: Drug Therapy & Brain Injury Written by Gregory O Shanick, MD Brain Injury Association of America Brain Injury Association of America Creating a better
4 DRUGS USED TO RELIEVE BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA
DEMENTIA Q&A 4 DRUGS USED TO RELIEVE BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA People with dementia may at some point in their illness develop behavioural or psychological symptoms. While it is
Update on guidelines on biological treatment of depressive disorder. Dr. Henry CHEUNG Psychiatrist in private practice
Update on guidelines on biological treatment of depressive disorder Dr. Henry CHEUNG Psychiatrist in private practice 2013 update International Task Force of World Federation of Societies of Biological
New Anticoagulants: When and Why Should I Use Them? Disclosures
Winship Cancer Institute of Emory University New Anticoagulants: When and Why Should I Use Them? Christine L. Kempton, MD, MSc Associate Professor of Pediatrics and Hematology and Medical Oncology Hemophilia
Psychopharmacology: A Comprehensive Review
Psychopharmacology: A Comprehensive Review 1) The association between a chemical compound and its biological activity, pioneered by Bovet and colleagues in the 1930s is known as a) Symbiosis b) Structure-activity
Managing potential drug-drug interactions to achieve success in HCV triple therapy. David Back University of Liverpool
Managing potential drug-drug interactions to achieve success in HCV triple therapy David Back University of Liverpool Understanding the metabolic pathways of DAAs Drug CYP 3A4 P-gp Telaprevir Boceprevir
Suicide in Bipolar Disorder. Julie Anderson, MD Oregon State Hospital Psychiatrist OHSU Assistant Professor September 25, 2012
Suicide in Bipolar Disorder Julie Anderson, MD Oregon State Hospital Psychiatrist OHSU Assistant Professor September 25, 2012 Disclosure Statement I have no significant financial relationships to disclose...
Drug Interactions with Smoke and Smoking Cessation Medications
Drug Interactions with Smoke and Smoking Cessation Medications Paul Oh MD MSc FRCPC FACP Medical Director, Toronto Rehab Assistant Professor, Division of Clinical Pharmacology, University of Toronto Disclosures
Drugs for Alcohol Dependence: Clinical Guidance and Three Way Agreement
Drugs for Alcohol Dependence: Clinical Guidance and Three Way Agreement for County Durham In partnership with the GP, the client, and the County Durham Drug and Alcohol Service December 2015 Version 1.0
EMORY CLINIC, INC. Brain Health Center 12 Executive Park Dr. Atlanta, GA 30329 404-728-6302
New Patient Packet 03/10/2015 EMORY CLINIC, INC. Brain Health Center 12 Executive Park Dr. Atlanta, GA 30329 404-728-6302 Thank you for allowing us to assist in your care. We look forward to meeting you.
Depression Flow Chart
Depression Flow Chart SCREEN FOR DEPRESSION ANNUALLY Assess for depression annually with the PHQ-9. Maintain a high index of suspicion in high risk older adults. Consider suicide risk and contributing
1/7/2012. Objectives. Epidemiology of Atrial Fibrillation(AF) Stroke in AF. Stroke Risk Stratification in AF
Objectives Atrial Fibrillation and Prevention of Thrombotic Complications: Therapeutic Update Andrea C. Flores Pharm.D Pharmacy Resident at the Miami VA Healthcare System Review the epidemiology, pathophysiology
PARTNERSHIP HEALTHPLAN OF CALIFORNIA MEDI-CAL PROVIDER MANUAL CLAIMS DEPARTMENT
PARTNERSHIP HEALTHPLAN OF CALIFORNIA MEDI-CAL PROVIDER MANUAL CLAIMS DEPARTMENT X.J. Mental Health Services 1. For claims with dates of service on or before January 1, 2014: Mental Health Services are
Conjoint Professor Brian Draper
Chronic Serious Mental Illness and Dementia Optimising Quality Care Psychiatry Conjoint Professor Brian Draper Academic Dept. for Old Age Psychiatry, Prince of Wales Hospital, Randwick Cognitive Course
Over the Counter Drugs (OTCs): Considerations for Physical Therapy Practice in Canada
Background Over the Counter Drugs (OTCs): Considerations for Physical Therapy Practice in Canada The use of medications or drugs by non-physician health professionals is evolving and is linked to collaboration
GUIDELINES FOR THE USE OF ATYPICAL ANTIPSYCHOTICS IN ADULTS. January 2012. 1 P a g e
GUIDELINES FOR THE USE OF ATYPICAL ANTIPSYCHOTICS IN ADULTS January 2012 1 P a g e First episode of psychosis or chronic psychosis First line: (equivalent choices, trial for 6 to 10 weeks) a) Risperidone
Teriflunomide is the active metabolite of Leflunomide, a drug employed since 1994 for the treatment of rheumatoid arthritis (Baselt, 2011).
Page 1 of 10 ANALYTE NAME AND STRUCTURE TERIFLUNOMIDE Teriflunomide TRADE NAME Aubagio CATEGORY Antimetabolite TEST CODE PURPOSE Therapeutic Drug Monitoring GENERAL RELEVANCY BACKGROUND sclerosis. The
